Published on 18 Oct 2022 on Simply Wall St. via Yahoo Finance

Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future

With the business potentially at an important milestone, we thought we'd take a closer look at Precipio, Inc.'s (NASDAQ:PRPO) future prospects. Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. With the latest financial year loss of US$8.5m and a trailing-twelve-month loss of US$11m, the US$19m market-cap company amplified its loss by moving further away from its breakeven target. Many investors are wondering about the rate at which Precipio will turn a profit, with the big question being “when will the company breakeven?” In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

View our latest analysis for Precipio

According to some industry analysts covering Precipio, breakeven is near. They anticipate the company to incur a final loss in 2023, before generating positive profits of US$6.4m in 2024. Therefore, the company is expected to breakeven roughly 2 years from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 71%, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.